Intuitive Surgical Inc. operates in the Health Care sector, within the Medical Devices industry. Founded in 1995, the company specializes in robotic-assisted surgical systems designed to support minimally invasive procedures.

Intuitive Surgical is best known for its da Vinci Surgical System, a robotic platform used in hospitals worldwide.

The system typically includes:

• A surgeon console providing high-definition 3D visualization and instrument control.

• A patient-side cart with robotic arms that manipulate surgical instruments.

• A vision system supporting imaging and visualization.

• Proprietary EndoWrist instruments designed for precise articulation.

The company’s portfolio includes robotic systems, surgical instruments, software, and service solutions that support a wide range of procedures, including urology, gynecology, general surgery, thoracic surgery, and oncology.

Its business model combines system sales, recurring revenue from disposable instruments and accessories, service agreements, and technology upgrades.

Intuitive Surgical operates globally, serving hospitals and surgical centers across North America, Europe, Asia, and other regions.

Performance is influenced by hospital capital spending, procedure volume growth, regulatory approvals, competition in robotic surgery, reimbursement policies, and innovation cycles in medical technology.

Intuitive Surgical shares trade on the Nasdaq under the ticker ISRG.

History and Development

Intuitive Surgical was founded in 1995 with the goal of advancing minimally invasive surgery through robotics.

In 2000, the company received U.S. regulatory clearance to commercialize the da Vinci Surgical System, marking a key milestone in robotic-assisted surgery.

That same year, Intuitive Surgical completed its initial public offering (IPO), providing capital to scale manufacturing and expand research and development.

Over the following decades, adoption of the da Vinci system increased steadily as hospitals integrated robotic-assisted procedures into surgical programs.

In recent years, the company has introduced updated system platforms, enhanced imaging capabilities, and expanded training programs for surgeons. It has also invested in software integration and workflow optimization to support operating room efficiency.

Today, Intuitive Surgical is positioned as a leading provider of robotic-assisted surgical technologies, with a business model centered on system placement and recurring procedure-based revenue.

Additional Information

Intuitive Surgical Inc. (United States) is listed on the Nasdaq and has a market capitalization of $129.41 billion, with shareholders equity totaling $18.30 billion.

The company employs approximately 8.081 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Intuitive Surgical Inc. reported $11.03 billion in revenue, generating net income of $3.16 billion.

Key financial metrics include a P/E ratio of 40.98, a price-to-book (P/B) ratio of 7.07, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker ISRG.